Clicky

Grifols Sa Barcelona(GIFLF) News

Date Title
Aug 29 Brookfield Courts Sovereign Funds to Join Grifols Takeover Bid
Aug 26 This Reviled Pharmaceutical Firm Holds Promise of a Healthier Future
Jul 29 Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients
Jun 18 Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
Jun 17 Biotest wins FDA approval for plasma protein therapy
Jun 17 Grifols prepares for late-stage plans with plasma-derived medicines in 2024
Jun 17 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies
May 9 Short Seller Gains on Grifols Bet That Tripped Elliott Spinout
Apr 14 Spanish drug maker Grifols will bring in independent directors, chairman tells newspaper
Mar 22 Grifols Drops as Regulator Finds ‘Relevant Deficiencies’
Jan 15 Here's Why Grifols (GRFS) is Poised for a Turnaround After Losing -31.55% in 4 Weeks
Jan 14 Grifols Says Haier Has Offered Reassurance on China Deal
Jan 14 Grifols says Haier Group still OK to buy stake in Shanghai RAAS
Jan 12 Grifols shares suffer worst week on record after short-seller report
Jan 12 Grifols Set for Biggest Weekly Drop Ever on Short Seller Tumult
Jan 11 Gotham Allegations ‘False,’ Grifols CEO Tells Investors
Jan 11 Grifols sees China stake sale going ahead despite Gotham City report
Jan 11 Grifols Faces Scrutiny of Billionaire Family’s Control
Jan 10 Gotham Slashes Grifols Short Position on Same Day as Selloff
Jan 10 Short Seller Attack Adds to Billionaire Grifols Dynasty Pain